Last $930.00 MXN
Change Today -27.50 / -2.87%
Volume 950.0
BNN On Other Exchanges
EN Paris
SIX Swiss Ex
As of 9:30 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

danone (BNN) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/14 - $986.00
52 Week Low
01/30/14 - $905.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DANONE (BNN)

Related News

No related news articles were found.

danone (BNN) Details

Danone produces and distributes food and beverage products. The company’s Fresh Dairy Products division provides yogurts, fermented fresh dairy products, and specialized dairy products under the Activia, Danonino, Fruchtswerge, Danoninho, Petit Gervais, Danimals, Serenito, Milkuat, Tëma, Actimel, Danacol, Densia, Oikos, Danio, Danette, Fantasia, Danissimo, YoCrunch, Vitalinea, Taillefine, and Ser brands. Its Waters division offers packaged natural, flavored, and vitamin-enriched water under Evian, Volvic, Bonafont, Mizone, Aqua, Fontvella, Lanjarón, Villavicencio, Villa del Sur, and Zywiec Zdroj brands. The company’s Early Life Nutrition division produces and distributes specialized food for babies and young children to complement breast-feeding, as well as solid foods for babies under Aptamil, Nutrilon, Almiron, Gallia, Bebelac, Cow&Gate, Blédina, and Malyutka brands. Its Medical Nutrition division provides specialized food for people receiving medical treatment, babies afflicted with certain illnesses, and frail elderly people. Its products include liquid oral nutritional supplements; hypoallergenic products; oral and feeding tube food products for the dietary treatment of infants and children who are incapable of feeding themselves or suffer from illness related malnutrition; and nutritional products for special medical needs. This division markets its products primarily under the Nutricia brand. The company serves individual consumers, retail chains, and traditional market outlets, as well as specialized distribution channels of hospitals, clinics, and pharmacies. It has operations in Russia, France, the United States, China, Indonesia, Spain, Mexico, Argentina, the United Kingdom, and Brazil. Danone has a strategic agreement with Starbucks to create and develop a line of Dannon-branded fresh dairy products. The company was formerly known as Groupe Danone and changed its name to Danone in April 2009. Danone was founded in 1899 and is based in Paris, France.

104,642 Employees
Last Reported Date: 03/24/14
Founded in 1899

danone (BNN) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: €2.5M
Vice Chairman, Co-Chief Operating Officer, De...
Total Annual Compensation: €1.4M
Vice Chairman and Deputy General Manager
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2013.

danone (BNN) Key Developments

Hospira Reportedly In Talks To Acquire Medical Nutrition Business

Danone (ENXTPA:BN) is in talks to sell its medical nutrition business to Hospira Inc. (NYSE:HSP). The negotiations have been going on for several weeks and, according to people familiar with the situation, both the parties are discussing the terms of a potential cash and stock deal that would value the business at close to $5 billion. The people cautioned that the talks were ongoing and no deal was certain, however. Nestlé S.A. (SWX:NESN) and Fresenius SE & Co KGaA (DB:FRE), had been interested in the medical nutrition business. However, it is not yet clear if they are still interested in the acquisition. JPMorgan has been hired by Danone to handle the sale process. Financial Times added that Danone and Hospira were not immediately available for comment.

Danone Reports Consolidated Earnings Results for the Second Quarter and First Half Ended June 30, 2014; Provides Earnings Guidance for the Year 2014

Danone reported consolidated earnings results for the second quarter and first half ended June 30, 2014. For the period, the company’s sales were €10,467 million against €11,058 million a year ago. Trading operating income was €1,180 million against €1,475 million a year ago. Underlying net income ­ Group share was €1,180 million against €1,475 million a year ago. Underlying net income ­ Group share was €683 million against €873 million a year ago. Underlying fully-diluted EPS was €1.16 against €1.48 a year ago. Net debt was €8,678 million as on June 30, 2014 against €7,966 million as on December 31, 2013. Pre-tax income was €925 million against €1,084 million a year ago. Net income per share before and after dilution was €1.03 against €1.64 a year ago. Capital expenditure was €20 million against €21 million a year ago. Cash-flow from operating activities was €641 million against €1,088 million a year ago. Operating income was €1,084 million against €1,184 million a year ago. For the quarter, the company reported sales of €5,406 million against €5,720 million a year ago. For the year 2014, the company expects like-for-like sales growth of between 4.5% and 5.5%. Trading operating margin expected to be stable within a range of -20 bps and +20 bps, reflecting the flexibility that the Group seeks to manage its operations, in particular for its Early Life Nutrition business in Asia. The company expects free cash-flow of around €1.5 billion excluding exceptional items.

Danone, H1 2014 Earnings Call, Jul 25, 2014

Danone, H1 2014 Earnings Call, Jul 25, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BNN:MM $930.00 MXN -27.50

BNN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.44 USD -0.10
Associated British Foods PLC 2,821 GBp -74.00
Baxter International Inc $75.28 USD +0.15
Fresenius SE & Co KGaA €36.82 EUR +0.105
Mondelez International Inc $36.18 USD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation BNN Industry Range
Price/Earnings 28.7x
Price/Sales 1.5x
Price/Book 2.8x
Price/Cash Flow 31.5x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANONE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at